Ignite Creation Date:
2025-12-24 @ 9:19 PM
Ignite Modification Date:
2026-01-24 @ 6:54 AM
Study NCT ID:
NCT00117104
Status:
COMPLETED
Last Update Posted:
2009-10-16
First Post:
2005-06-30
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Evaluating Aranesp® in Subjects With End Stage Renal Disease onChronic Hemodialysis
Sponsor:
Amgen
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | End Stage Renal Disease | View |